Clinical Trial Update: A Phase 1/2, Randomized, Placebo-controlled, Observer-blinded Trial To Evaluate The Safety, Tolerability, And Immunogenicity Of A Multivalent Group B Streptococcus Vaccine In Healthy Adults 18 To 49 Years Of Age [Phase 2]

View source ↗

Summary

Phase 1/2 randomized trial evaluating a multivalent Group B Streptococcus vaccine in healthy adults; study completed with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Group Streptococcal Infections

Drugs mentioned

• Multivalent Group B Streptococcus Vaccine (Group B Streptococcus vaccine (multivalent))

Snippet

Sponsor: Pfizer | Conditions: Group B Streptococcal Infections | Phase 2 | Status: COMPLETED | Results posted: 2019-07-02